rs3087409

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_000553.6(WRN):​c.1577-3C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0631 in 1,607,294 control chromosomes in the GnomAD database, including 3,545 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.077 ( 509 hom., cov: 32)
Exomes 𝑓: 0.062 ( 3036 hom. )

Consequence

WRN
NM_000553.6 splice_region, intron

Scores

2
Splicing: ADA: 0.3898
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.54

Publications

17 publications found
Variant links:
Genes affected
WRN (HGNC:12791): (WRN RecQ like helicase) This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]
WRN Gene-Disease associations (from GenCC):
  • Werner syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • osteosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 8-31088887-C-A is Benign according to our data. Variant chr8-31088887-C-A is described in ClinVar as [Benign]. Clinvar id is 130753.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.126 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WRNNM_000553.6 linkc.1577-3C>A splice_region_variant, intron_variant Intron 12 of 34 ENST00000298139.7 NP_000544.2 Q14191

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WRNENST00000298139.7 linkc.1577-3C>A splice_region_variant, intron_variant Intron 12 of 34 1 NM_000553.6 ENSP00000298139.5 Q14191
WRNENST00000521620.5 linkn.278-3C>A splice_region_variant, intron_variant Intron 1 of 22 1
WRNENST00000650667.1 linkn.*1191-3C>A splice_region_variant, intron_variant Intron 11 of 33 ENSP00000498593.1 A0A494C0M3

Frequencies

GnomAD3 genomes
AF:
0.0769
AC:
11674
AN:
151838
Hom.:
508
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.128
Gnomad AMI
AF:
0.107
Gnomad AMR
AF:
0.0424
Gnomad ASJ
AF:
0.0453
Gnomad EAS
AF:
0.0239
Gnomad SAS
AF:
0.0795
Gnomad FIN
AF:
0.0697
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0599
Gnomad OTH
AF:
0.0686
GnomAD2 exomes
AF:
0.0566
AC:
13833
AN:
244582
AF XY:
0.0566
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0252
Gnomad ASJ exome
AF:
0.0435
Gnomad EAS exome
AF:
0.0208
Gnomad FIN exome
AF:
0.0679
Gnomad NFE exome
AF:
0.0561
Gnomad OTH exome
AF:
0.0495
GnomAD4 exome
AF:
0.0616
AC:
89699
AN:
1455338
Hom.:
3036
Cov.:
31
AF XY:
0.0621
AC XY:
44901
AN XY:
723534
show subpopulations
African (AFR)
AF:
0.129
AC:
4310
AN:
33364
American (AMR)
AF:
0.0275
AC:
1218
AN:
44328
Ashkenazi Jewish (ASJ)
AF:
0.0446
AC:
1157
AN:
25956
East Asian (EAS)
AF:
0.0231
AC:
914
AN:
39556
South Asian (SAS)
AF:
0.0737
AC:
6280
AN:
85262
European-Finnish (FIN)
AF:
0.0662
AC:
3512
AN:
53034
Middle Eastern (MID)
AF:
0.0618
AC:
338
AN:
5466
European-Non Finnish (NFE)
AF:
0.0616
AC:
68316
AN:
1108320
Other (OTH)
AF:
0.0608
AC:
3654
AN:
60052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3886
7773
11659
15546
19432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2588
5176
7764
10352
12940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0770
AC:
11694
AN:
151956
Hom.:
509
Cov.:
32
AF XY:
0.0756
AC XY:
5616
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.128
AC:
5322
AN:
41452
American (AMR)
AF:
0.0423
AC:
646
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.0453
AC:
157
AN:
3464
East Asian (EAS)
AF:
0.0237
AC:
123
AN:
5184
South Asian (SAS)
AF:
0.0798
AC:
385
AN:
4826
European-Finnish (FIN)
AF:
0.0697
AC:
737
AN:
10572
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0600
AC:
4071
AN:
67884
Other (OTH)
AF:
0.0688
AC:
145
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
555
1111
1666
2222
2777
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0634
Hom.:
1475
Bravo
AF:
0.0765
Asia WGS
AF:
0.0620
AC:
216
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Werner syndrome Benign:4
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 01, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Wiskott-Aldrich syndrome Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
10
DANN
Benign
0.73
PhyloP100
1.5
Mutation Taster
=82/18
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.39
dbscSNV1_RF
Benign
0.23
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3087409; hg19: chr8-30946403; API